Literature DB >> 15897903

Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.

Zoya N Demidenko1, AnnaMaria Rapisarda, Mercedes Garayoa, Paraskevi Giannakakou, Giovanni Melillo, Mikhail V Blagosklonny.   

Abstract

In the presence of oxygen and iron, hypoxia-inducible factor (HIF-1alpha) is rapidly degraded via the prolyl hydroxylases (PHD)/VHL pathways. Given striking similarities between p53 and HIF-1alpha regulation, we previously suggested that HIF-1 transcriptionally initiates its own degradation and therefore inhibitors of transcription must induce HIF-1alpha. Under normoxia, while inducing p53, inhibitors of transcription did not induce HIF-1alpha. Under hypoxia or low iron (DFX), inhibitors of transcription dramatically super-induced HIF-1alpha. Removal of inhibitors resulted in outburst of the HIF-1-dependent transcription followed by depletion of HIF-1alpha. Although hypoxia/DFX induced PHD3, we excluded the PHD/VHL pathway in the regulation of HIF-1alpha under hypoxia/DFX. The transcription-dependent degradation of HIF-1alpha under hypoxia occurs via the proteasome and is accelerated by protein acetylation. Thus, HIF-1alpha is regulated by two distinct mechanisms. Under normoxia, HIF-1alpha is degraded via the classic PHD/VHL pathway, is expressed at low levels and therefore does not activate the feedback loop. But under hypoxia, HIF-1alpha accumulates and transcriptionally activates its own degradation that is independent from the PHD/VHL pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897903     DOI: 10.1038/sj.onc.1208636

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  The EPAS1 gene influences the aerobic-anaerobic contribution in elite endurance athletes.

Authors:  Jennifer Henderson; Jason M Withford-Cave; David L Duffy; Stuart J Cole; Nicole A Sawyer; Jason P Gulbin; Allan Hahn; Ronald J Trent; Bing Yu
Journal:  Hum Genet       Date:  2005-10-06       Impact factor: 4.132

2.  Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.

Authors:  A Lo Dico; S Valtorta; C Martelli; S Belloli; U Gianelli; D Tosi; S Bosari; A Degrassi; M Russo; I Raccagni; G Lucignani; R M Moresco; L Ottobrini
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 3.  Hypoxia inducible factor-1: its potential role in cerebral ischemia.

Authors:  Neetu Singh; Gaurav Sharma; Vikas Mishra
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

Review 4.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents.

Authors:  Jessica Jie Wei Lou; Yee Liu Chua; Eng Hui Chew; Jie Gao; Martin Bushell; Thilo Hagen
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

Review 6.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

7.  Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.

Authors:  Zhao-Li Zhou; Zhi-Guo Luo; Bing Yu; Yi Jiang; Yi Chen; Jian-Ming Feng; Mei Dai; Lin-Jiang Tong; Zheng Li; Yuan-Chao Li; Jian Ding; Ze-Hong Miao
Journal:  Mol Cancer       Date:  2010-10-11       Impact factor: 27.401

8.  Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction.

Authors:  Xian-Jun Ke; Jun-Jian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

9.  Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.

Authors:  Donna M Fath; Xianguo Kong; Dongming Liang; Zhao Lin; Andrew Chou; Yubao Jiang; Jie Fang; Jaime Caro; Nianli Sang
Journal:  J Biol Chem       Date:  2006-03-15       Impact factor: 5.157

Review 10.  HAF : the new player in oxygen-independent HIF-1alpha degradation.

Authors:  Mei Yee Koh; Garth Powis
Journal:  Cell Cycle       Date:  2009-05-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.